BCM
PFE icon

Bluefin Capital Management’s Pfizer PFE Stock Holding History

Bluefin Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Sell
39,754
-32,788
-45% -$873K 0.72% 28
2025
Q4 		$1.81M Buy
+72,542
New +$1.83M 0.45% 31
2025
Q3 		– Sell
-17,327
Closed -$420K – 141
2025
Q2 		$420K Sell
17,327
-73
-0.4% -$1.7K 0.32% 52
2025
Q1 		$441K Buy
+17,400
New +$455K 0.32% 47
2024
Q3 		$404K Buy
13,969
+3,400
+32% +$99.2K 0.12% 56
2024
Q2 		$296K Buy
10,569
+869
+9% +$23.9K 0.07% 58
2024
Q1 		$269K Buy
+9,700
New +$269K 0.04% 79
2023
Q4 		– Sell
-10,800
Closed -$326K – 292
2023
Q3 		$358K Buy
+10,800
New +$382K 0.03% 76
2023
Q1 		– Sell
-32,754
Closed -$1.68M – 404
2022
Q4 		$1.68M Sell
32,754
-31,308
-49% -$1.5M 0.25% 63
2022
Q3 		$2.8M Buy
64,062
+17,882
+39% +$869K 0.25% 71
2022
Q2 		$2.35M Buy
46,180
+24,980
+118% +$1.27M 0.26% 70
2022
Q1 		$1.1M Sell
21,200
-234,879
-92% -$12.2M 0.1% 122
2021
Q4 		$15.1M Buy
256,079
+76,021
+42% +$3.77M 1.06% 26
2021
Q3 		$7.75M Sell
180,058
-4,149
-2% -$184K 0.77% 22
2021
Q2 		$7.21M Buy
184,207
+85,770
+87% +$3.34M 0.46% 39
2021
Q1 		$3.57M Buy
98,437
+37,800
+62% +$1.34M 0.17% 82
2020
Q4 		$2.23M Buy
+60,637
New +$2.22M 0.13% 92
2020
Q3 		– Hold
0
– – – 96
2020
Q2 		– Sell
-8,116
Closed -$276K – 447
2020
Q1 		$251K Sell
8,116
-216,378
-96% -$7.37M 0.03% 232
2019
Q4 		$8.35M Buy
224,494
+213,822
+2,004% +$7.62M 0.55% 46
2019
Q3 		$364K Buy
+10,672
New +$388K 0.05% 208
2018
Q4 		– Sell
-14,174
Closed -$592K – 512
2018
Q3 		$592K Buy
14,174
+4,583
+48% +$176K 0.05% 210
2018
Q2 		$330K Sell
9,591
-1,265
-12% -$43.2K 0.03% 246
2018
Q1 		$366K Sell
10,856
-14,155
-57% -$487K 0.02% 229
2017
Q4 		$860K Sell
25,011
-28,685
-53% -$978K 0.05% 181
2017
Q3 		$1.82M Buy
53,696
+30,777
+134% +$989K 0.21% 84
2017
Q2 		$730K Buy
22,919
+10,278
+81% +$324K 0.08% 194
2017
Q1 		$410K Sell
12,641
-32,612
-72% -$1.03M 0.05% 218
2016
Q4 		$1.4M Buy
45,253
+8,483
+23% +$259K 0.09% 124
2016
Q3 		$1.18M Buy
36,770
+26,196
+248% +$876K 0.04% 115
2016
Q2 		$353K Buy
10,574
+5,479
+108% +$175K 0.04% 238
2016
Q1 		$143K Sell
5,095
-244,817
-98% -$6.99M 0.01% 322
2015
Q4 		$7.65M Buy
249,912
+161,765
+184% +$5.09M 0.61% 35
2015
Q3 		$2.63M Sell
88,147
-135,504
-61% -$4.34M 0.16% 98
2015
Q2 		$7.12M Buy
223,651
+122,370
+121% +$3.99M 0.43% 51
2015
Q1 		$3.34M Sell
101,281
-10,596
-9% -$337K 0.31% 79
2014
Q4 		$3.31M Sell
111,877
-19,411
-15% -$557K 0.2% 118
2014
Q3 		$3.68M Buy
131,288
+90,638
+223% +$2.54M 0.2% 115
2014
Q2 		$1.2M Buy
40,650
+7,052
+21% +$201K 0.05% 277
2014
Q1 		$1M Buy
+33,598
New +$1M 0.06% 220
2013
Q3 		– Sell
-1,297,354
Closed -$34.4M – 520
2013
Q2 		$34.4M Buy
+1,297,354
New +$35.8M 3.23% 2

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bluefin Capital Management's PFE Position: Q1 2026 in Review

Bluefin Capital Management reduced its Pfizer (PFE) stake by 45% in Q1 2026, selling an estimated $873K and leaving 39,754 shares worth $1.12M. The position accounts for 0.72% of the portfolio, ranked #28.

Bluefin Capital Management first reported a position in PFE in Q2 2013 and has held it in 40 quarters since. The position peaked at $34.4M in Q2 2013. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Bluefin Capital Management held 39,754 shares of Pfizer worth $1.12M as of Q1 2026.
  • Bluefin Capital Management sold 32,788 Pfizer shares in Q1 2026, an estimated $873K.
  • Pfizer made up 0.72% of Bluefin Capital Management's portfolio in Q1 2026, its #28 holding.
  • Bluefin Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 40 quarters since.
  • Bluefin Capital Management's Pfizer position peaked at $34.4M in Q2 2013.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bluefin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.